Dewpoint to Collaborate with Pfizer on Muscular Dystrophy

Posted by ISPE Boston
On January 14, 2021

Dewpoint Therapeutics has announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of myotonic dystrophy type 1 (DM1), a rare genetic disorder and one of two types of myotonic dystrophy. Under the agreement, Dewpoint will receive an upfront payment and will be eligible to receive research, development, and […]

bluebird bio to Split into Two Separate Companies

Posted by ISPE Boston
On January 14, 2021

bluebird bio has announced its intent to separate its severe genetic disease (SGD) and oncology businesses into differentiated and independent publicly traded companies. bluebird bio, Inc. will retain focus on SGD and will launch its oncology business (“Oncology Newco”) as a new entity. Upon completion of the separation, current chief bluebird, Nick Leschly, will lead Oncology […]

Agios to Sell Its Oncology Business for Up to $2 Billion

Posted by ISPE Boston
On January 14, 2021

Agios Pharmaceuticals has entered into a definitive agreement to sell its commercial, clinical and research-stage oncology portfolio to Servier, an independent global pharmaceutical company for which it will receive a cash consideration of up to $2.0 billion, including $1.8 billion in upfront cash. Agios plans to move forward with a singular focus on its genetically defined disease portfolio, including […]

A TEMPlate for the Future of Biomanufacturing

Posted by ISPE Boston
On January 13, 2021

ARMI | BioFabUSA will be offering a members-only series of technical workshops centered on advanced manufacturing technologies for Tissue Engineered Medical Products (TEMPs). In this exciting workshop series, you will hear from ARMI|BioFabUSA and its community members about the latest advancements in equipment, measurement, materials, and processes toward achieving scalable, modular, automated, and closed manufacturing for […]

Single Use Technologies – Unanswered Questions

Posted by Aaron Hubbell
On January 12, 2021

Up until a few years ago, single use technologies were pitched as “the way of the future;” a solution to high capital investments in new facilities, a way to speed equipment changeover, and a path to reduced energy and water use. Most of us would agree that single-use is no longer “the future,” but truly […]

Provide Your Feedback Here on a New Type of Chapter Program

Posted by Howard Sneider
On January 7, 2021

Though the advent of vaccines will eventually allow a return to normalcy, we still need to use protective safety measures for the foreseeable future. The associated restrictions have forced the world to adapt and learn how to do things in new ways. This includes the Boston Area Chapter and the types of programs it offers. […]

Chapter Member Anniversaries: January 2021

Posted by ISPE Boston
On January 6, 2021

Please congratulate the following members celebrating milestone anniversaries in January 2021. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael Anderson, FST Technical Services LLC Daniel Baxter, Vertex Pharmaceuticals Incorporated Dr. Anthony Bevilacqua, PhD, Mettler-Toledo Thornton Inc Erik Caldwell, Northeast Water Svcs, Inc. Brian Charron, PE, Mylan […]

Welcome New Members December 2020!

Posted by ISPE Boston
On January 6, 2021

We would like to introduce the Members who joined ISPE in December 2020, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Technology Transfer Project Management Best Practices in the Era of COVID-19

Posted by Charlie Maher
On December 28, 2020

Technology transfer is essential to advancing pharmaceutical products from development, through clinical and into commercial operation. The complexity of transferring the production of a product from a sending unit to the receiving unit is challenging even in the best of conditions. Since the onset of the COVID-19 pandemic the industry has shifted into high gear […]

MassBio’s Robert Coughlin to Grow Life Sciences Industry Practice at JLL

Posted by ISPE Boston
On December 28, 2020

Robert Coughlin, departing President and CEO of the Massachusetts Biotechnology Council, will join the JLL Brokerage team as Managing Director in the firm’s Life Sciences industry practice in early 2021. JLL is a registered trademark of Jones Lang LaSalle, a Fortune 500 real estate and investment management company with annual revenue of $18.0 billion in […]

Page 52 of 116«‹50 515253 54 ›»